• Dr. Domb!

    Thanks a lot for getting my hip right. Looking forward to a full recovery and a great season. Thanks again for everything.

    Corey WoottonChicago Bears and Detroit Lions
  • Thank you for all that you have done for me and the team. My hip feels so much better, and because of you I'm pain free.
    Sylvia Fowles WNBA Finals MVP, 2-time Olympic Gold Medalist
  • Thank you for working your magic! You're the best!
    Zakiya BywatersChicago Red Stars, National Women's Soccer League
  • Thanks for all the love and positive Energy that was put into my surgery. May the Lord bless you and your family.
    Atari BigbyGreen Bay Packers and San Diego Chargers
  • Dr. Domb, Thanks for fixing me up
    Rashied DavisChicago Bears
  • Huge thank you to Dr. Domb for always taking care of me and getting me back on the court in no time!
    Elena Delle DonneChicago Sky, MVP of the WNBA
  • Dr. Domb! Thanks for taking care of the hip! All the best to you and your staff
    Roosevelt ColvinChicago Bears' All-Decade Defense team
  • Thanks doc for fixing my hip!
    Ryan ChiaveriniWindy City Live Co-Host on ABC7

2014 - Domb et al. The Effect of Liposomal Bupivacaine Injection During Total Hip Arthroplasty A Controlled Cohort Study - BMC Musculoskeletal Disorders

Background: Multimodal analgesia following total hip arthroplasty has been shown to improve patient satisfaction,participation with physical therapy, and allow early return to self care. Liposomal bupivacaine is a formulation of local anesthetic which has the potential to provide anesthesia for up to 72 hours following administration. The purpose of this study was to compare the effectiveness of liposomal bupivacaine with bupivacaine following total hip arthroplasty.

Methods: A retrospective chart review was performed on 28 patients undergoing total hip arthroplasty or hipresurfacing who received intraoperative administration of liposomal bupivacaine. A control group of 30 patients who had previously undergone total hip arthroplasty or hip resurfacing and had received intraoperative administration of bupivacaine also underwent a chart review. Length of stay, post-operative opioid use, and painscores were compared for both groups.

Results: The average length of stay in the study group was 1.93 days and the control group length of stay was2.47 days (p ≤ 0.05). Morphine equivalent use was less in the study group during the first 24 hours compared to the control group (p ≤0.05). During the second and third 24 hours the morphine equivalent use difference was not statistically significant. Visual analogue scores were not significantly different between groups at any time point.

Conclusion: Liposomal bupivacaine administration during total hip arthroplasty appears to decrease the need for opioid use post operatively and decrease length of stay. The results of this study justify the need for a well-designed randomized controlled trial utilizing liposomal bupivacaine as part of multimodal analgesia during THA.

 Click here to download the complete publication